We found that breast CSCs showed downregulation of CHIP expression and regulation of post-translational modification of OCT4, a stemness factor, because OCT4 dosage is important for determining cell fate of embryonic stem cells and cancer tumorigenesis. This evidence concerns the gene POU5F1 and cancer.